Other languages Vicore Pharma Holding AB

Equities

VICO

SE0007577895

Market Closed - Nasdaq Stockholm Other stock markets 11:29:39 2024-04-26 am EDT			5-day change	1st Jan Change
17.3 ^SEK	+3.72%		+6.00%	+22.00%

Apr. 04	Vicore Pharma Holding AB Announces Maarten Kraan, as Board Member Declined Re-Election	CI
Mar. 19	Vicore Announces FDA Breakthrough Device Designation for AlmeeTM, a Digital Therapy for Patients with Pulmonary Fibrosis	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vicore Pharma Holding AB Announces Maarten Kraan, as Board Member Declined Re-Election	Apr. 04
Vicore Announces FDA Breakthrough Device Designation for AlmeeTM, a Digital Therapy for Patients with Pulmonary Fibrosis	Mar. 19
Vicore Pharma Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28
Vicore Pharma Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28
Vicore Pharma Signs Licensing Deal for Idiopathic Pulmonary Fibrosis Drug Candidate	Feb. 09
Alex Therapeutics and Vicore Pharma Announces Positive Results of the COMPANION Study	Jan. 04
Vicore Pharma Holding AB Confirms IPF Development Program on Track and Provides Early-Stage Pipeline Updates	Jan. 02
Vicore Pharma Holding AB Appoints Bertil Lindmark as Chief Medical Officer	Dec. 18
Vicore Pharma Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02
Vicore Pharma Holding AB Announces the Nomination Committee for the 2024 Annual General Meeting	23-10-31
Vicore Pharma Holding AB Provides Update Regarding Phase 1 Study of C106	23-10-27
Vicore Pharma's New CEO to Formally Take Office	23-09-08
Vicore Pharma Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24
Vicore Pharma Holding AB Reports Data from EndoPAT® Exploratory Trial	23-08-22
Vicore Pharma Names New CEO to Start in September	23-07-13
Vicore Pharma Holding AB Announces Executive Changes	23-07-13
Vicore Pharma Initiates Recruitment Process as CEO Plans Retirement	23-07-05
EU Grants Patent to Vicore Pharma's Improved Pulmonary Fibrosis Drug Candidate	23-06-07
Vicore Pharma Holding AB Reports New 36-Week Data from the Air Trial Demonstrating Sustainable Disease Stimulating the Potential of A New Class of Drugs to Stop Disease Propose and Restate in IPF Patients	23-05-19
Vicore Pharma Holding AB Strengthens Its Board of Directors	23-05-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Vicore Pharma Holding AB

Equities

VICO

SE0007577895

Other languages

Filters